Similar articles

• A prospective randomized comparison of a single antibiotic (moxalactam) versus combination therapy (gentamicin and clindamycin) in penetrating abdominal trauma.

  Fifer T, Obeid FN, Horst HM, Sorensen VJ, Crots LD, Bivins BA. Fifer T, et al. Henry Ford Hosp Med J. 1988;36(1):52-5. Henry Ford Hosp Med J. 1988. PMID: 3397299 Clinical Trial. No abstract available.
• Third-generation cephalosporins for polymicrobial surgical sepsis.

  Stone HH, Strom PR, Fabian TC, Dunlop WE. Stone HH, et al. Arch Surg. 1983 Feb;118(2):193-200. doi: 10.1001/archsurg.1983.01390020047009. Arch Surg. 1983. PMID: 6295339 Clinical Trial.
• Ceftriaxone versus combined gentamicin and clindamycin for polymicrobial surgical sepsis.

  Stone HH, Mullins RJ, Strom PR, Bourneuf AA, Geheber CE. Stone HH, et al. Am J Surg. 1984 Oct 19;148(4A):30-4. Am J Surg. 1984. PMID: 6091478 Clinical Trial.
• [Pharmacokinetics, in vitro activity and clinical experience with lamoxactam].

  Klech H, Fiser I. Klech H, et al. Schweiz Rundsch Med Prax. 1983 Mar 15;72(11):369-78. Schweiz Rundsch Med Prax. 1983. PMID: 6221244 Review. German. No abstract available.
• New drug evaluations: moxalactam (Moxam, Eli Lilly).

  Polk RE. Polk RE. Drug Intell Clin Pharm. 1982 Feb;16(2):104-12. doi: 10.1177/106002808201600203. Drug Intell Clin Pharm. 1982. PMID: 6210519 Review.